A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

Clinical trial NCT07223125 · RECRUITING

Trial details

NCT number: NCT07223125
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced-stage Solid Tumors

Start date: 2025-10-10
Primary completion: 2026-12-15
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.